Trial site
Instytut Matki i Dziecka
- 10running trials
- 5closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers12 trials
- Sarcoma4 trials
- Cytomegalovirus infection1 trial
- Endometriosis1 trial
- Epilepsy1 trial
- Neuroblastoma1 trial
- Phase
- Phase 210 trials
- Phase 34 trials
- Phase 2/31 trial
- Status
- Completed5 trials
- Active, not recruiting4 trials
- Recruiting4 trials
- Not yet recruiting2 trials
- Lead sponsor
- Instytut Matki I Dziecka6 trials
- GPOH gGmbH1 trial
- Gustave Roussy, Cancer Campus, Grand Paris1 trial
- Hope Medicine (Nanjing) Co., Ltd1 trial
- Institut Gustave Roussy1 trial
- and 5 more
Running trials
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma.
Recruiting
Active, not recruiting
To evaluate the efficacy and safety of regorafenib in patients with refractory primary bone tumors.
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers5 recruiting
- Sarcoma3 recruiting
- Cytomegalovirus infection1 recruiting
Closed trials
Recruiting
Completed
Completed
A Study to Assess the Efficacy and Safety of HMI-115 in Subjects With Endometriosis-Associated Pain
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026